 | | Therapy |
Give soluble insulin
a
in low-doses (e.g. 5 to 10 units per hour)
a
intravenously
d
at regular intervals or continuously
d
An insulin infusion regimen d
Add 50 units of actrapid (soluble) insulin to 50 ml
of 0.9% saline. Infuse using the following sliding scale.
| Glucose (mmol/l) |
Infusion rate (units/hr) |
|
0 to 4
|
0.5 and 10% or 20% glucose infusion
|
|
4 to 8
|
1
|
|
8 to 12
|
2
|
|
12 to 16
|
3
|
|
16 to 20
|
4
|
|
> 20
|
6 and call doctor
|
The regimen may need to be adjusted depending on your
patient’s response.
Why?
-
A low-dose insulin regimen is less likely to cause
hypoglycaemia
or
hypokalaemia
than a high-dose one.
a
-
There is no clear difference in the time taken to return to biochemical normality.
a
A low-dose insulin regimen reduces the risk of
hypoglycaemia
or
hypokalaemia
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
diabetic ketoacidosis
a
|
low-dose insulin
|
high-dose insulin
|
hypoglycaemia
mol/l)
at
12
hours
|
25%
|
100%
|
4
(2 to
13)
|
|
|
|
|
hypokalaemia
(< 3.4 mmol/l)
at
12
hours
|
29%
|
86%
(-7% to
98%)
|
4
(2 to
19)
|
-
The route used to administer insulin in patients has no clear effect on the time taken to return to biochemical normality or the amount of insulin required.
d
-
A continuous insulin infusion is not clearly more likely to cause a faster fall in glucose levels nor shorten the time to reach a glucose <14
mmol/l than a bolus followed by regular injections.
d
|